EPO Patents = 3

Forward Citations = 20

Loading Chart...

11 inventors (with patents filed for the assignee):

Joaquin Pastor Fernández (3 out of 5 patents)

Sonia Martínez González (2 out of 6 patents)

Julen Oyarzabal Santamarina (2 out of 2 patents)

4. Paolo Pevarello (1 out of 48 patents)

5. Manuel Serrano Marugan (1 out of 1 patent)

6. Ana Ortega Molina (1 out of 1 patent)

7. James R Bischoff (1 out of 1 patent)

8. Ana Maria Garcia Collazo (1 out of 2 patents)

9. Guido Kurz (1 out of 1 patent)

10. Sonia Martínez Gonzalez (1 out of 1 patent)

11. Ana Belen Garcia Garcia (1 out of 1 patent)

12. Joaquín Pastor Fernández (4 patents)

13. Ana Isabel Hernández Higueras (2 patents)

14. Antonio Rodríguez Hergueta (4 patents)

15. Carmen Blanco Aparicio (3 patents)

4 patents: Sort by Forward Citations

1. 9993554 - Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing (2018-06-12),

2. 8815918 - Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives (2014-08-26),

3. 8778935 - Imidazopyrazines for use as kinase inhibitors (2014-07-15),

4. 8563550 - Imidazolothiadiazoles for use as protein kinase inhibitors (2013-10-22),

Centro Nacional de Investigaciones Oncológicas (CNIO) is a leading cancer research center located in Madrid, Spain. CNIO conducts cutting-edge research in cancer biology, genetics, and molecular oncology, with the aim of understanding the underlying mechanisms of cancer and developing new and more effective treatments. CNIO collaborates with national and international institutions to advance cancer research and improve outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#66 in Madrid

#490 in Spain

Madrid, Spain

Centro Nacional De Investigaciones Oncologicas (Cnio)